VolitionRX (VNRX) Stock Price, Quote, News & History | Benzinga

SPY779.87+0.10%QQQ759.84+0.02%BTC/USD84,192.09−1.58%DIA514.66+0.02%GLD381.90−0.10%TLT77.20−0.10%

VolitionRX Ltd (VNRX) Stock Price, Quote, News & History

VNRXAMEX

Trade with Public

Trade with Public

$0.2429

0.01094.7%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Stock Report

Key Statistics

Open

$0.23

Close

$0.24

Volume / Avg.

644.26K / 8.19M

Day Range

$0.23 - $0.25

52 Wk Range

0.23 - 13.40

Market Cap

$6.97M

P/E Ratio

-

Dividend Yield

-

Exchange

AMEX

RSI

28

Short Interest

3.4%

Days to Cover

1

Recent VolitionRX Ltd News

Nasdaq Surges 200 Points; Nvidia Posts Upbeat Q2 Results

US stocks traded higher with Nasdaq up 200 points. Dow down 0.01%, Nasdaq up 0.77%, and S&P 500 up 0.27%. Tech shares rose 2.2% while consumer staples fell 1.1%. Nvidia reported strong earnings. Propanc Biopharma up 211%, VolitionRX up 86%, Mint Incorporation up 74%, Alpha Modus down 25%, Change Agents down 29%, and Xiao-I down 21%.

Avi Kapoor

Penny Stock VolitionRx Expands Addressable Markets With Key Diagnostic Validations

VolitionRx reports 112% revenue growth in H1 2026 while advancing its Nu.Q diagnostic platforms across sepsis and oncology markets.

Vandana Singh

Why Salesforce Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket

Salesforce Inc (NYSE: CRM) stock rose on good Q2 results and raised FY27 guidance, while other tech stocks saw gains in early trading.Salesforce (NYSE: CRM) jumps on strong Q2 results and raised guidance, tech stocks up in pre-market trading.

Avi Kapoor

Why Bolt Projects Holdings Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Levi Strauss, USANA Health Sciences And 3 Stocks To Watch Heading Into Friday

US stock futures up, Apogee Enterprises, Levi Strauss, VolitionRX, USANA Health Sciences, Nurix Therapeutics report results.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-19.56M

Investing Cash Flow (TTM)

-21.97K

Financing Cash Flow (TTM)

20.35M

Free Cash Flow (TTM)

-19.58M

Capital Expenditure (TTM)

-21.97K

Net Change in Cash (TTM)

766.59K

Analyst Trends and Forecast

0

0

0

0

Apr

1

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$15.59M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

0.65

PB Ratio (TTM)

-

Earnings Yield % (TTM)

-1659.48%

Earnings Yield % (FWD)

-77.59%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

-$1.07

Company Debt

Total Debt

$10.71M

LT Debt

$6.22M

LT Debt Issuance (TTM)

$3.13M

LT Debt Repayment (TTM)

-$2.03M

Total Cash

$2.79M

Debt to Equity

-

Issuance of Debt (TTM)

$1.10M

Repayment of Debt (TTM)

-$2.03M